These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7023714

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer.
    Falkson G, van Eden EB, Falkson HC.
    Cancer; 1974 May; 33(5):1207-9. PubMed ID: 4595974
    [No Abstract] [Full Text] [Related]

  • 3. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ, Falkson G.
    Med Pediatr Oncol; 1975 May; 1(2):107-11. PubMed ID: 1228411
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB, Falkson G, van Dyk JJ, van der Merwe AM, Falkson HC.
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma.
    Moon JH, Gailani S, Cooper MR, Hayes DM, Rege VB, Blom J, Falkson G, Maurice P, Brunner K, Glidewell O, Holland JF.
    Cancer; 1975 Feb; 35(2):368-71. PubMed ID: 1111913
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 5-Fluorouracil (NSC-19893), DTIC (NSC-45388), BCNU (NSC-409962), and vincristine (NSC-67574) in advanced colorectal carcinoma.
    von Eyben FE, Larsen V, Pedersen H.
    Cancer Treat Rep; 1976 Jan; 60(1):29-32. PubMed ID: 1000517
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG, Schutt AJ, Hahn RG, Reitemeier RJ.
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Mitchell RB, Dolan ME.
    Cancer Chemother Pharmacol; 1993 Jan; 32(1):59-63. PubMed ID: 8462125
    [Abstract] [Full Text] [Related]

  • 18. Phase II study of DTIC, ACNU, and vincristine combination chemotherapy for supratentorial malignant astrocytomas.
    Ikeda J, Aida T, Sawamura Y, Abe H, Kaneko S, Kashiwaba T, Kawamoto T, Mitsumori K, Saitoh H.
    Neurol Med Chir (Tokyo); 1996 Aug; 36(8):555-8; discussion 558-9. PubMed ID: 8831197
    [Abstract] [Full Text] [Related]

  • 19. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
    Stroehlein JR, Bedikian AY, Karlin DA, Valdivieso M, Bennetts RW, Bodey GP.
    Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964
    [Abstract] [Full Text] [Related]

  • 20. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
    Bellett RE, Mastrangelo MJ, Laucius JF, Bodurtha AJ.
    Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.